TOP STORIES
Theranos takes another punch: “A federal inspection report said a Theranos Inc. laboratory ran an important blood test on 81 patients in a six-month period despite erratic results from quality-control checks meant to ensure the test’s accuracy.” – The Wall Street Journal
This has a long way to go, but it’s worth watching. Proposed federal legislation would provide a tax credit to family caregivers: working families could get an annual credit of up to 30 percent of caregiving expenses or $3,000, whichever is less. – The Hill
The Power of Real World Data to Study Women’s Health at Scale
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
LIFE SCIENCES
Canon and Fujifilm are in the lead to take over Toshiba’s medical equipment unit. We’ll know more by end of day Wednesday. – Reuters
Get another CRISPR patent preview (it begins Wednesday). “If you can’t come up with evidence that proves your case, like a dated, witnessed, and signed lab notebook, you lose. A tie will go to the senior party.” – STAT
AbbVie has launched a collaboration with Boehringer Ingelheim around its late-stage psoriasis drug. AbbVie delivers $595 million in an upfront payment to Boehringer, as well as access to other earlier-stage immunology treatments. – FierceBiotech
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
Spark Therapeutics has bought the Irish gene therapy company Genable Technologies for $15 million. Spark will use the Genable’s assets to develop a treatment for the eye disease rhodopsin-linked autosomal dominant retinitis. – FierceDrugDelivery
Valeant shares were rallying on the same day it scheduled a new guidance update for a week from now. – Forbes
Stentys is expanding into Europe. – MassDevice
Argos Therapeutics nabbed $60 million in financing to finance late-stage clinical trials for its immune-based kidney cancer treatment. – Xconomy
FWIW, here’s a company that got $4 million to develop cricket-based protein bars. – PE Hub
PAYERS-PROVIDERS
Get a better look at Ohio-based Mercy Health’s new CEO. – Cincinnati Business Courier
Zika updates:
- HHS is shipping blood and blood products to Puerto Rico because local supplies may be contaminated with Zika.- NBC News
- It looks like additional federal funds to fight Zika won’t leave Congress. – STAT
About 3,500 registered nurses at Sutter Health hospitals won pay increases ranging from 20 percent to 28 percent over four years. – Sacramento Business Journal
We have promising results of the first uterus transplant in the United States. – The New York Times
TECHNOLOGY
MD Anderson rolled out its new Epic EMR build. – Houston Business Journal
Blackrun Ventures has launched a new investment platform that targets businesses for whom women are the end-consumer. Among its first investments: a maternal health technology company. – PR Newswire
POLITICS
There will be no far-reaching probe from Health and Human Services about high drug prices (thanks, Obama). – The Hill
Health Savings Accounts are a big deal in many of the GOP presidential candidates’ Obamacare replacement plans. Now if we could only figure out exactly what those plans are. – Modern Healthcare
A LITTLE BIT EXTRA
I am enjoying my slow plod through my early 40s. But I would also disagree with this assertion: that the late-20s are the worst times of your life. – Harvard Business Review
Photo: Getty Images